IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 13,315

Sort by:

Exanthema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exanthema markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.32% during...

May 2024 134 pages

Exocrine Pancreatic Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major exocrine pancreatic insufficiency markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.0 Billion by 2034, exhibiting a growth rat...

May 2024 128 pages

Extensive-Stage Small Cell Lung Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major extensive-stage small cell lung cancer markets are expected to exhibit a CAGR of 7.6% during 2024-2034. The extensive-stage small cell lung cancer market has been comprehensively analyzed...

May 2024 131 pages

Failed Back Surgery Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major failed back surgery syndrome markets reached a value of US$ 13.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 19.6 Billion by 2034, exhibiting a growth rate (...

May 2024 129 pages

Fallopian Tube Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fallopian tube cancer markets are expected to exhibit a CAGR of 6.96% during 2024-2034. The fallopian tube cancer market has been comprehensively analyzed in IMARC's new report titled 'Fal...

May 2024 132 pages

Familial Adenomatous Polyposis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial adenomatous polyposis markets are expected to exhibit a CAGR of 4.23% during 2024-2034. The familial adenomatous polyposis market has been comprehensively analyzed in IMARC's new...

May 2024 138 pages

Familial Mediterranean Fever Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial Mediterranean fever markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The familial Mediterranean fever market has been comprehensively analyzed in IMARC's new repo...

May 2024 134 pages

Familial Primary Pulmonary Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major familial primary pulmonary hypertension markets reached a value of US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.2 Billion by 2034, exhibiting a grow...

May 2024 133 pages

Fanconi Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fanconi anemia markets reached a value of US$ 49.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 78.8 Million by 2034, exhibiting a growth rate (CAGR) of 4.38%...

May 2024 134 pages

Febrile Neutropenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major febrile neutropenia markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

Fecal Incontinence Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fecal incontinence markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3.8...

May 2024 140 pages

Female Infertility Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major female infertility markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.7...

May 2024 129 pages

Fibrodysplasia Ossificans Progressiva Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibrodysplasia ossificans progressiva markets reached a value of US$ 361.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 503.8 Million by 2034, exhibiting a gr...

May 2024 138 pages

Fibromyalgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fibromyalgia markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 2.69% dur...

May 2024 135 pages

Filariasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major filariasis markets are expected to exhibit a CAGR of 7.92% during 2024-2034. The filariasis market has been comprehensively analyzed in IMARC's new report titled 'Filariasis Market: Epidem...

May 2024 139 pages

Focal Segmental Glomerulosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major focal segmental glomerulosclerosis markets reached a value of US$ 332.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 578.0 Million by 2034, exhibiting a growt...

May 2024 135 pages

Follicular Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major follicular lymphoma markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 129 pages

Food Allergy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major food allergy markets reached a value of US$ 2,199.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,425.2 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 134 pages

Fragile X Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fragile X syndrome markets reached a value of US$ 43.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 66.9 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 136 pages

Friedreich's Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Friedreich's ataxia markets reached a value of US$ 600.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,710.7 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Frontotemporal Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major frontotemporal dementia markets reached a value of US$ 123.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 596.3 Million by 2034, exhibiting a growth rate (CAG...

May 2024 138 pages

Fuchs Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Fuchs dystrophy markets reached a value of US$ 148.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 292.9 Million by 2034, exhibiting a growth rate (CAGR) of 6....

May 2024 131 pages

Functional Dyspepsia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major functional dyspepsia markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 135 pages

Functional Neurological Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major functional neurological disorder markets reached a value of US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.1 Billion by 2034, exhibiting a growth ra...

May 2024 130 pages

Fungal Lung Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major fungal lung diseases markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The fungal lung diseases market has been comprehensively analyzed in IMARC's new report titled 'Funga...

May 2024 128 pages

Galactosemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major galactosemia markets reached a value of US$ 341.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 501.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.57%...

May 2024 137 pages

Gallbladder Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gallbladder cancer markets reached a value of US$ 51.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 66.8 Million by 2034, exhibiting a growth rate (CAGR) of 2...

May 2024 130 pages

Ganglion Cyst Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ganglion cyst markets are expected to exhibit a CAGR of 5.38% during 2024-2034. The ganglion cyst market has been comprehensively analyzed in IMARC's new report titled 'Ganglion Cyst Marke...

May 2024 129 pages

Gastritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastritis markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The gastritis market has been comprehensively analyzed in IMARC's new report titled 'Gastritis Market: Epidemiol...

May 2024 139 pages

Gastro Esophageal Junction Neuroendocrine Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastro esophageal junction neuroendocrine tumor markets reached a value of US$ 1,059.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,965.3 Million by 2034, e...

May 2024 130 pages

Gastroesophageal Junction Adenocarcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastroesophageal junction adenocarcinoma markets are expected to exhibit a CAGR of 13.82% during 2024-2034. The gastroesophageal junction adenocarcinoma market has been comprehensively ana...

May 2024 128 pages

Gastroesophageal Reflux Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastroesophageal reflux disease markets are expected to exhibit a CAGR of 1.21% during 2024-2034. The gastroesophageal reflux disease market has been comprehensively analyzed in IMARC's ne...

May 2024 132 pages

Gastrointestinal Stromal Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gastrointestinal stromal tumor markets reached a value of US$ 493.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 810.2 Million by 2034, exhibiting a growth ra...

May 2024 128 pages

Generalized Anxiety Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major generalized anxiety disorder markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.4 Billion by 2034, exhibiting a growth rate (CA...

May 2024 138 pages

Generalized Pustular Psoriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major generalized pustular psoriasis markets reached a value of US$ 18.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.5 Billion by 2034, exhibiting a growth rate...

May 2024 139 pages

Genital Herpes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major genital herpes markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The genital herpes market has been comprehensively analyzed in IMARC's new report titled 'Genital Herpes Ma...

May 2024 132 pages

Genital Warts Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major genital warts markets reached a value of US$ 813.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,335.5 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 137 pages

Geographic Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major geographic atrophy markets reached a value of US$ 24.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 44.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5...

May 2024 131 pages

Germ Cell Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major germ cell tumor markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.7 Billion by 2034, exhibiting a growth rate (CAGR) of 8.91%...

May 2024 140 pages

Gestational Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gestational diabetes markets are expected to exhibit a CAGR of 4.77% during 2024-2034. The gestational diabetes market has been comprehensively analyzed in IMARC's new report titled 'Gesta...

May 2024 128 pages

Giant Cell Arteritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major giant cell arteritis markets reached a value of US$ 1,130.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,825.2 Million by 2034, exhibiting a growth rate (CA...

May 2024 139 pages

Gingivitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gingivitis markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.27 Billion by 2034, exhibiting a growth rate (CAGR) of 3.85% duri...

May 2024 129 pages

Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major glioma markets reached a value of US$ 1.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.83% during 20...

May 2024 134 pages

Gliosarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gliosarcoma markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.38% duri...

May 2024 134 pages

Glomerulonephritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major glomerulonephritis markets reached a value of US$ 748.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,105.0 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 140 pages

Glycogen Storage Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major glycogen storage disease markets are expected to exhibit a CAGR of 5.76% during 2024-2034. The glycogen storage disease market has been comprehensively analyzed in IMARC's new report title...

May 2024 131 pages

Gonorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gonorrhea markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.4 Billion by 2034, exhibiting a growth rate (CAGR) of 2.35% during...

May 2024 136 pages

Gorlin Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Gorlin syndrome markets reached a value of US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.1 Billion by 2034, exhibiting a growth rate (CAGR) of 7.6%...

May 2024 131 pages

Gout Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major gout markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.7 Billion by 2034, exhibiting a growth rate (CAGR) of 10.42% during 202...

May 2024 133 pages

Graft vs Host Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major Graft vs Host Disease markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.2 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Filters

Clear all